A randomized, controlled study to evaluate safety of Vildagliptin in patients with type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 23 Jul 2015
At a glance
- Drugs Vildagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.